What is a stock summary page? Click here for an overview.
Business Description
NeuroMetrix Inc
NAICS : 339112
SIC : 3841
ISIN : US6412557083
Description
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 103.74 | |||||
| Equity-to-Asset | 0.93 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -13.27 | |||||
| Beneish M-Score | -3.96 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -33.9 | |||||
| 3-Year EBITDA Growth Rate | -8.6 | |||||
| 3-Year EPS without NRI Growth Rate | -4.3 | |||||
| 3-Year FCF Growth Rate | -3.1 | |||||
| 3-Year Book Growth Rate | 6 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.13 | |||||
| 9-Day RSI | 48.73 | |||||
| 14-Day RSI | 51.94 | |||||
| 3-1 Month Momentum % | 11.42 | |||||
| 6-1 Month Momentum % | 11.7 | |||||
| 12-1 Month Momentum % | 5.53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 13.88 | |||||
| Quick Ratio | 12.7 | |||||
| Cash Ratio | 12.26 | |||||
| Days Inventory | 345.92 | |||||
| Days Sales Outstanding | 39.39 | |||||
| Days Payable | 56.98 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -47.6 | |||||
| Shareholder Yield % | -32.81 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 57.56 | |||||
| Operating Margin % | -230.41 | |||||
| Net Margin % | -203.72 | |||||
| FCF Margin % | -177.49 | |||||
| ROE % | -41.7 | |||||
| ROA % | -38.58 | |||||
| ROIC % | -413.47 | |||||
| 3-Year ROIIC % | -448.71 | |||||
| ROC (Joel Greenblatt) % | -513.61 | |||||
| ROCE % | -47.01 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.87 | |||||
| PB Ratio | 0.57 | |||||
| Price-to-Tangible-Book | 0.57 | |||||
| EV-to-EBIT | 0.65 | |||||
| EV-to-EBITDA | 0.66 | |||||
| EV-to-Revenue | -1.49 | |||||
| EV-to-FCF | 0.84 | |||||
| Price-to-GF-Value | 1.64 | |||||
| Price-to-Median-PS-Value | 2.77 | |||||
| Price-to-Net-Current-Asset-Value | 0.59 | |||||
| Price-to-Net-Cash | 0.67 | |||||
| Earnings Yield (Greenblatt) % | 153.85 | |||||
| FCF Yield % | -72.17 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:NURO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
NeuroMetrix Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 3.768 | ||
| EPS (TTM) ($) | -4.234 | ||
| Beta | 0.83 | ||
| 3-Year Sharpe Ratio | -0.88 | ||
| 3-Year Sortino Ratio | -1.1 | ||
| Volatility % | 20.8 | ||
| 14-Day RSI | 51.94 | ||
| 14-Day ATR ($) | 0.074625 | ||
| 20-Day SMA ($) | 4.409605 | ||
| 12-1 Month Momentum % | 5.53 | ||
| 52-Week Range ($) | 2.66 - 4.73 | ||
| Shares Outstanding (Mil) | 2.05 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
NeuroMetrix Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
NeuroMetrix Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
NeuroMetrix Inc Frequently Asked Questions
What is NeuroMetrix Inc(NURO)'s stock price today?
The current price of NURO is $4.51. The 52 week high of NURO is $4.73 and 52 week low is $2.66.
When is next earnings date of NeuroMetrix Inc(NURO)?
The next earnings date of NeuroMetrix Inc(NURO) is 2025-03-28 Est..
Does NeuroMetrix Inc(NURO) pay dividends? If so, how much?
NeuroMetrix Inc(NURO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers